ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LLOY Lloyds Banking Group Plc

58.78
0.28 (0.48%)
17 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Lloyds Banking Group Plc LSE:LLOY London Ordinary Share GB0008706128 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.28 0.48% 58.78 58.84 58.86 59.10 58.52 58.64 74,999,869 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Commercial Banks, Nec 23.74B 5.46B 0.0859 6.85 37.19B
Lloyds Banking Group Plc is listed in the Commercial Banks sector of the London Stock Exchange with ticker LLOY. The last closing price for Lloyds Banking was 58.50p. Over the last year, Lloyds Banking shares have traded in a share price range of 39.55p to 59.64p.

Lloyds Banking currently has 63,569,225,662 shares in issue. The market capitalisation of Lloyds Banking is £37.19 billion. Lloyds Banking has a price to earnings ratio (PE ratio) of 6.85.

Lloyds Banking Share Discussion Threads

Showing 345626 to 345642 of 430650 messages
Chat Pages: Latest  13830  13829  13828  13827  13826  13825  13824  13823  13822  13821  13820  13819  Older
DateSubjectAuthorDiscuss
28/1/2021
23:07
The EU’s new rules on jab exports would potentially hit supplies of the first three western-made vaccines to come to market, as all have manufacturing operations in the EU. BioNTech/Pfizer supplies the whole world apart from the US from its Belgian plant, while Moderna produces its non-US vaccine supply in Switzerland but fills and finishes the vials in Spain.

AstraZeneca produces jabs in Belgium and the Netherlands, as well as the UK.




Don’t mess with The Daddy little boys.

minerve 2
28/1/2021
22:49
A positive for Lloyd's is at the moment we (UK) are above their upside scenario and well below book price.
gaffer73
28/1/2021
22:47
I see they are running a clinical trial on that Jordaggy, will be interesting to see the results the early findings show some promise. Another vaccine also shows some promise this evening, will require a multipronged approach.
dr biotech
28/1/2021
22:44
Well said psychochopper Bang on
jkitwm
28/1/2021
22:26
Seems now that every call the MRHA and the JCVI have made has been absolutely correct.

Note that the head of the BMA opposed their strategy - he should resign immediately.

Also, now Novavax (American) has been shown to be very good. Trialed in the U.K. and will be made in the U.K. 60mn doses on order. We should flog them to the EU at £50 a pop. NZ and Australia at a fiver.

We’re good at this science stuff.

psychochopper
28/1/2021
22:19
I'm in a similar position with my holding and have been adding all year. I'm hoping the divi is reinstated when the results come out next month. If they do I think this will move back over 40p but also put me back on track with my long term plan, I can write a year off but won't be happy with two.Regarding future lockdowns, l can't see any happening, people won't stand for it once this is all over.PRA will have a hard time justifying another ban with the extra provisions Lloyd's have in place, but never say never hey!
gaffer73
28/1/2021
22:09
Wouldn't waste your time jordaggy.

Dr Biotech doesn't accept anything that the establishment doesn't peddle.
He'll probably come up with some lies claiming you've said XYZ when you haven;t as well for good measure.

Then he will intimate, or smear you as an anti vaxxer!!!

DrBiotech thinks he is better than most.
That's why he is a Remainer.

geckotheglorious
28/1/2021
22:06
539. Well put. I think anyway.Goodnight.
xxxxxy
28/1/2021
22:05
First real-world data on vaccination effectiveness shows 'really promising' resultsInitial figures appear to justify the delayed second dose approach, according to the JCVIByHenry Bodkin, HEALTH AND SCIENCE CORRESPONDENT28 January 2021 • 8:23pmThe first real-world data on the effectiveness of the vaccination programme shows "really promising" results, a member of the official vaccine committee has revealed.Professor Anthony Harnden, deputy chairman of the Joint Committee on Vaccination and Immunisation (JCVI) also said initial figures appeared to justify the delayed second dose approach.He said the data – at this stage mainly relating to the Pfizer jab – shows that a "substantial proportion" of patients are protected after the first dose.It came the day after Boris Johnson announced he would publish the strategy to exit lockdown in the week of February 22, based significantly on vaccine efficacy results.Professor Harnden said that while the JCVI had not reviewed hospital admissions or deaths at its meeting on Thursday, he expected the results to be even better than those for infection prevention.Public Health England are expected to formally publish findings within the next fortnight."I've just come off JCVI and we're looking at these real-time vaccine effectiveness figures, it's really early stages yet, but it does look like our first dose strategy is proving to be a good one," said Prof Harnden.... Full article... Daily Telegraph
xxxxxy
28/1/2021
21:29
All the AZ vaccines have to go to Germany.

They have put their beach towels on them.

joestalin
28/1/2021
21:14
The 4th Reich is faltering, I wouldnt be suprised to find von der leyen & Merv in a bunker tomorrow naked & covered in meat & potato pies.
utrickytrees
28/1/2021
20:53
This is easily my worst performing investment and my largest holding, still I kind of agree with gaffer, there will be economic pain ahead, there is no doubt about that, however, I know many people who have done rather well out of lockdown and with nothing to spend their money on there will be a wall of cash waiting to be spent. Many, and I include myself, have been paying down debt, all of which could benefit LLOY and the economy as a whole.

My main worry is how will the Government react if COVID numbers rise again in the winter or we have a bad flu, Lockdown's are now in their toolkit, will this be the go-to policy every time we have a virus, that would be economically catastrophic and bad news for LLOY. My second concern is around the payment of dividends, I can live with a near -30% fall in my original investment if they resume the dividend. A Conservative Government wouldn't normally interfere in a private company's dividend policy, but, this is a Conservative Government in name only and further restrictions on banks' ability to pay dividends can't be ruled out. The PRA may do this against a backdrop of millions losing their jobs and homes with the banks expected to conserve cash to 'help the economy', we are all in this together after all.

I hope my concerns are unfounded,

wllm :)

wllmherk
28/1/2021
20:43
AstraZeneca is a scapegoat for the European Commission's staggering institutional failure

Ursula von der Leyen’s Davos speech this week sounded more like a threat than a request for Britain's help



AMBROSE EVANS-PRITCHARD
27 January 2021 • 8:38pm
Ambrose Evans-Pritchard





Brussels wants Britons to die so that Europeans should live. That is the implication of diverting up to 75 million doses of AstraZeneca’s vaccine to the EU market. It is a large demand.

Diplomatically, this country can invoke vital national interest and restrict exports of doses manufactured in the UK, just as the EU has announced it will do for doses made on its own territory. Whether this country should act in such a fashion is a question of statecraft.

But it would be a remarkably generous gesture at a time when the EU is being horrible on everything to do with the post-Brexit settlement, from customs clearance, to Ulster, or financial equivalence. It is reciprocating on almost nothing.

Personally, as a man in my early sixties, I might forgo my jab for a while so that the over eighties at greater risk in France, Italy, or Bulgaria can be saved, although why do they have a greater claim than Tanzanians? But the EU does not seem to be making a moral request for solidarity. It is issuing orders.

Ursula von der Leyen’s speech to the virtual Davos forum this week did not sound like a request for help from this country. It sounded like a threat. Companies must “honour their obligations”, she said in her teeth-clenching staccato style.

Health commissioner Stella Kyriakides says AstraZeneca is legally bound to divert doses from two UK factories. "In our contract it is not specified that any country or the UK has priority. This needs to be absolutely clear," she said.

You would hardly know that AstraZeneca is the saviour in this saga, not the villain. It is making no profit from the vaccine. It is selling at cost, like a charity, offering a humanitarian service to the world. But don’t expect gratitude from the Berlaymont.

Nor is there any hint of acknowledgement that Brussels got itself into its vaccine disaster by haggling over prices and trying to drive hard bargains on indemnity. It wasted three months before committing to AstraZeneca, as if it were the easiest thing in the world to mass-produce a viral vector vaccine. That is why the EU-based plants are not yet up to full efficiency.

The UK and the US invested seven times as much public money per capita to accelerate the vaccine breakthrough, acting with war-time energy while the Commission remained stuck in its bureaucratic box-ticking subculture, catering to the lowest common denominator of 27 states. If ever there was an example of why Brussels should not be let anywhere near policies of real national sensitivity, this was it.

EuroIntelligence said the EU conducted vaccine talks in the same spirit that it conducted Brexit talks. “It tried to lock in a perceived short-term price advantage at the expense of everything else,” it said. Speed is everything in a pandemic. The Commission could not see the wood for the trees.

I have no idea whether AstraZeneca’s Pascal Soriot is right in claiming that the company has no contractual duty to deliver tens of million doses to the EU by a fixed date, but rather only to make its “best effort”. Nor do I know whether vaccine supply-chain is set up for each specific country. The issue is larger.



All of a sudden the stereotype roles of the last four years have reversed. Europe’s technocrats are now the populists, the vaccine imperialists. Borisian Britain is starting to feel like a haven of calm by comparison. For all its mistakes, the UK is now cleaving closer to science. It is behaving better.

Germany is in fever, hunting for somebody to blame for the inexcusable fact that it cannot obtain more than a trickle of its own BioNTech vaccine. If that blame ultimately lands squarely on Brussels, the European project is in trouble.

For now media wrath is turning on diversionary scapegoats. AstraZeneca is the easiest target. Hysteria is taking over. One can only guess which figures in ‘government circles’ (Kreisen der Bundesregierung) leaked a fabricated story to the Handelsblatt alleging that its vaccine is virtually useless against the elderly.

The claim has been shot down by German scientists. AstraZeneca has debunked it. Oxford University, unused to such political bloodsport, gently pointed out that five peer-reviewed papers show that efficacy is comparable across age groups. Not a single elderly volunteer died or became critically-ill after the jab.

No matter. The fake news lives on, amplified by Bild Zeitung, and still given credence by others, as if there were a genuine debate. This mendacious virus is now a staple of social media and lodged in the German mind. That is how to destroy confidence in a vaccination campaign. Kreisen der Bundesregierung indeed.

France’s rationalist president is like a rabbit caught in the headlights. The ‘variant anglais’ has surged to 10pc of all Covid cases in greater Paris even on the lagging official data. It is going parabolic. The scientific authorities are pressing for an immediate lockdown. Still he hesitates.

Emmanuel Macron is warily eyeing the travails of his friend and fellow-rationalist Mark Rutte. The Netherlands have been blind-sided by violent anti-curfew riots for three consecutive nights, “shameless thieves” in the words of Rotterdam’s mayor, or “the scum” to one minister.

Macron knows that civic acquiescence for his stop-go strategy is near breaking point. Consent for yet another lockdown has dropped to 40pc. A gilets jaunes two lies in store if this drags on deep into the Spring.


The EU’s vaccination debacle has delayed Europe’s social reopening and economic recovery by three months, with all the consequences that this will have for sovereign debt ratios, small firm solvency, and labour hysteresis.

It is one reason - though not the only one - why the International Monetary Fund thinks the region will be left behind as the US and China roar back this year. It is a Sino-American G2 world from now on. The pandemic has brought forward Europe’s definitive relegation from the top league.

The IMF and other global bodies lump the UK with the worst of Europe in their grim forecasts. The Fund thinks growth will be just 4.5pc this year after a 10pc contraction in 2020. The OECD says the UK will be the laggard of the developed world, far behind even France and Italy.

If that happens, I will eat my hat (another one). Britain’s vaccination success so far - and a steeper relative trajectory over coming weeks - imply a rebound roughly ten weeks sooner. So long as Rishi Sunak restrains the Treasury from fiscal tightening too soon, it may well be a V-shaped take-off.

The Office for National Statistics will publish a paper next week showing that the UK’s (best practice) method of measuring health and education in GDP figures exaggerated the fall in GDP last year. We cut ‘output’ when doctors see fewer patients, or schools have fewer classes. Other countries measure differently.

This flattered German GDP by roughly 2pc last year, or French and Italian GDP by around 1pc. The opposite effect will kick as life returns to normal. It is the UK recovery that will be flattered.

My bet: the UK will be the star of the big European economies this year and may clock up 6pc growth as pent-up investment flows, assuming the IMF is broadly right on world growth. The Brexit trade shock will be less than feared.

The UK’s flexible labour markets will make the switch to the post-Pandemic digital economy better than Germany, France, or Italy. Sterling will be the foreign exchange darling. The FTSE-250 will be the catch up story of 2021.

The global narrative on Brexit will become less relentlessly hostile. It will be the mirror image of Europe’s eroding credibility. Who knows, perhaps even the Scots will feel that they have judged our imperfect but interwoven union a little too harshly.

maxk
28/1/2021
20:03
Boris just a wild boar
Shortlty to be killed

jl5006
28/1/2021
20:01
The mong BJ party need to wake up.
This is the management of our economy by their inability to tie their shoe laces - just waste any amount of money to ACHIEVE - anthing - and the missing letter is the meaning.
He must have had his day the cliffs of dover will succeed him - they will fall as he will.
End of

jl5006
28/1/2021
19:59
Well said asa8....the enemy within.

Nice one Boris....telling the wee beastie most Scots think independence debate irrelevant to them. That'll wind her up to a tee.

cheshire pete
28/1/2021
19:56
Dr. B, just for you...a 3 minute watch.
jordaggy
Chat Pages: Latest  13830  13829  13828  13827  13826  13825  13824  13823  13822  13821  13820  13819  Older

Your Recent History

Delayed Upgrade Clock